These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 25980509)

  • 1. Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.
    Fabbri C; Serretti A
    Curr Psychiatry Rep; 2015 Jul; 17(7):50. PubMed ID: 25980509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic studies: a tool to improve antidepressant therapy.
    Ramos M; Berrogain C; Concha J; Lomba L; García CB; Ribate MP
    Drug Metab Pers Ther; 2016 Dec; 31(4):197-204. PubMed ID: 27889704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.
    Bousman CA; Stevenson JM; Ramsey LB; Sangkuhl K; Hicks JK; Strawn JR; Singh AB; Ruaño G; Mueller DJ; Tsermpini EE; Brown JT; Bell GC; Leeder JS; Gaedigk A; Scott SA; Klein TE; Caudle KE; Bishop JR
    Clin Pharmacol Ther; 2023 Jul; 114(1):51-68. PubMed ID: 37032427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics in major depression: a comprehensive meta-analysis.
    Niitsu T; Fabbri C; Bentini F; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant pharmacogenetics in children and young adults: A systematic review.
    Maruf AA; Greenslade A; Arnold PD; Bousman C
    J Affect Disord; 2019 Jul; 254():98-108. PubMed ID: 31112844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of genetic polymorphisms related to neurotransmitters and cytochrome P-450 enzymes in response to antidepressants.
    Lee MS
    Drugs Today (Barc); 2007 Aug; 43(8):569-81. PubMed ID: 17925888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders.
    Poweleit EA; Aldrich SL; Martin LJ; Hahn D; Strawn JR; Ramsey LB
    J Child Adolesc Psychopharmacol; 2019 Jun; 29(5):348-361. PubMed ID: 31066578
    [No Abstract]   [Full Text] [Related]  

  • 9. Genome-wide association studies in pharmacogenomics of antidepressants.
    Lin E; Lane HY
    Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of mood disorders: what clinicians need to know.
    Laje G
    CNS Spectr; 2013 Oct; 18(5):272-84. PubMed ID: 24050155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients and clinicians report higher-than-average satisfaction with psychiatric genotyping for depressed inpatients.
    Kung S; Allen JD
    J Clin Psychiatry; 2011 Feb; 72(2):262-3. PubMed ID: 21382312
    [No Abstract]   [Full Text] [Related]  

  • 13. A Prospective Study of Serotonin and Norepinephrine Transporter Genes and the Response to Desvenlafaxine Over 8 Weeks in Major Depressive Disorder.
    Ng CH; Bousman C; Smith DJ; Dowling N; Byron K; King J; Sarris J
    Pharmacopsychiatry; 2016 Sep; 49(5):210-212. PubMed ID: 27023264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.
    Lett TA; Walter H; Brandl EJ
    CNS Drugs; 2016 Dec; 30(12):1169-1189. PubMed ID: 27752945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics of antidepressant treatment effects.
    Licinio J; Wong ML
    Dialogues Clin Neurosci; 2011; 13(1):63-71. PubMed ID: 21485747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.
    Helton SG; Lohoff FW
    Pharmacogenomics; 2015; 16(5):541-53. PubMed ID: 25916524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTR2A gene variation is involved in antidepressant treatment response.
    Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further Support for the Involvement of Genetic Variants Related to the Serotonergic Pathway in the Antidepressant Response in Children and Adolescents After a 12-Month Follow-Up: Impact of the
    Gassó P; Blázquez A; Rodríguez N; Boloc D; Torres T; Mas S; Lafuente A; Lázaro L
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):711-718. PubMed ID: 29975559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.